In8Bio (INAB) Price to Book (2021 - 2026)
In8Bio's (INAB) quarterly Price to Book came in at 1.49 in Q2 2026, up 167.25% year-over-year from 0.56 in Q2 2025, and up 18.19% quarter-over-quarter from 1.26 in Q1 2026.
Analysis
In8Bio (INAB) Price to Book (2021 - 2026) Analysis & Trends
In8Bio has disclosed Price to Book across 6 years of filings, most recently posting 1.49 for Q2 2026.
- In Q2 2026, Price to Book rose 167.25% year-over-year to 1.49; the TTM figure through Jun 2026 stood at 1.49 (up 167.25% YoY), while the FY2025 annual figure was 0.37, down 60.92% from the prior year.
- Price to Book came in at 1.49 for Q2 2026 at In8Bio, up from 1.26 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 2.89 in Q2 2024 to a low of 0.11 in Q1 2024.
- Average Price to Book over 5 years is 1.45, with a median of 1.55 recorded in 2022.
- Year-over-year, Price to Book tumbled 94.5% in 2024 and soared 814.79% in 2025.
- Over 5 years, Price to Book stood at 2.49 in 2022, then plunged by 33.74% to 1.65 in 2023, then plunged by 42.49% to 0.95 in 2024, then tumbled by 60.92% to 0.37 in 2025, then soared by 302.44% to 1.49 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 1.49 in Q2 2026, 1.26 in Q1 2026, and 0.37 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | In8Bio | 23.36 Mn | 23.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 |
| Mar 31, 2026 | 1.26 |
| Dec 31, 2025 | 0.37 |
| Sep 30, 2025 | 0.76 |
| Jun 30, 2025 | 0.56 |
| Mar 31, 2025 | 0.97 |
| Dec 31, 2024 | 0.95 |
| Sep 30, 2024 | 1.47 |
| Jun 30, 2024 | 2.89 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 1.65 |
| Sep 30, 2023 | 1.87 |
| Jun 30, 2023 | 2.16 |
| Mar 31, 2023 | 1.93 |
| Dec 31, 2022 | 2.49 |
| Sep 30, 2022 | 1.67 |
| Jun 30, 2022 | 1.60 |
| Mar 31, 2022 | 1.91 |
| Dec 31, 2021 | -1.15 |
| Sep 30, 2021 | 2.13 |